Boosting Mesothelioma Survival with VEGF-Inhibitor
The VEGF inhibitor cediranib may not yet be out of the running as a mesothelioma treatment. Although previous studies have…
-
-
Alternatives | Asia | International | Multi-Modality Therapy | New Drugs | New Studies | Research | Treatments
Cholesterol Drug May Protect Mesothelioma Patients from Radiation
A new study suggests that the cholesterol-lowering drug pravastatin could one-day be used to help protect mesothelioma patients from the… -
Alternatives | Immune Systems | Immunotherapy | Multi-Modality Therapy | Prognosis | Research | Treatments | Virus
Altered Viruses May Help Boost Immunotherapy for Malignant Mesothelioma
Viruses may soon be playing a bigger role in the fight against malignant mesothelioma and other thoracic cancers. A pair… -
Chemotherapy | Europe | International | Multi-Modality Therapy | New Studies | Research | Treatments
Standardization Needed for Peritoneal Mesothelioma Treatment
Mesothelioma researchers in Belgium and the US have some good news and some bad news about peritoneal mesothelioma treatment. The… -
Immune Systems | Immunotherapy | Multi-Modality Therapy | New Studies | Radiation Therapy | Research
Immunotherapy and Radiation: A Powerful Mesothelioma Combo
New research suggests that, in the battle against malignant pleural mesothelioma, a treatment combining immunotherapy drugs with radiotherapy may be a powerful… -
Europe | International | Multi-Modality Therapy | New Studies | Radiation Therapy | Research | Treatments
IMRT Beats Conformal Radiotherapy for Pleural Mesothelioma
The targeted radiotherapy technique known as intensity-modulated radiotherapy (IMRT) may offer a safer way to treat pleural mesothelioma tumors with… -
New Report May Fuel Debate Over Mesothelioma Surgery
A new Swiss report on the two major types of mesothelioma surgery appears to raise as many questions as it… -
VEGF-Inhibitor Looks Promising for Malignant Mesothelioma
There is more encouraging news about the monoclonal antibody bevacizumab (Avastin) and its potential to boost the effectiveness of chemotherapy… -
Asia | Chemotherapy | International | Multi-Modality Therapy | New Studies | Research | Surgery | Treatments
Additional Chemotherapy Extends Survival in Relapsed Mesothelioma Patients
Mesothelioma patients who experience a recurrence of their asbestos cancer after radical surgery may live longer if they undergo additional… -
New Evidence Supports Post-Surgical IMRT for Mesothelioma Treatment
Just a week after New York researchers published their own study on radiation therapy and mesothelioma surgery, a group of…
